NCT03217487
Unknown
Not Applicable
A Randomized Controlled Clinical Trial of Corneal Epithelial Autograft for the Treatment of Limbal Stem Cell Deficiency
Chunxiao Wang1 site in 1 country20 target enrollmentStarted: July 25, 2017Last updated:
ConditionsLimbal Stem Cell Deficiency
Overview
- Phase
- Not Applicable
- Sponsor
- Chunxiao Wang
- Enrollment
- 20
- Locations
- 1
- Primary Endpoint
- Restoration of corneal surface in the diseased eye
Overview
Brief Summary
The purpose of the study is to explore whether femtosecond laser-assisted corneal epithelial autograft is more effective than limbal conjunctival autograft for ocular surface reconstruction in patients with limbal stem cell deficiency (LSCD).
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Parallel
- Primary Purpose
- Treatment
- Masking
- None
Eligibility Criteria
- Ages
- 14 Years to 80 Years (Child, Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Unilateral LSCD secondary to ocular burns, with the duration of disease of at least 24 months at the time of screening visit;
- •Presence of superficial neo-vascularization affecting at least 2 cornea quadrants and involving central cornea;
- •Informed consent signed by patient or legal guardian. Having the ability to comply with study assessments for the full duration of the study.
Exclusion Criteria
- •LSCD of mild degree, with less than 2 quadrants of neo-vessel invasion and without central cornea involvement;
- •LSCD by ocular surface disorders other than pterygium;
- •Eyelids malposition;
- •The center corneal thickness\<450µm, the depth of corneal opacity \> 150µm;
- •High myopia with a spherical equivalent of -15.0 D or less;
- •Corneal or ocular surface infection within 30 days prior to study entry;
- •Ocular surface malignancy;
- •Uncontrolled diabetes with most recent Hemoglobin A1c greater than 8.5%;
- •Renal failure with creatinine clearance\< 25ml/min;
- •Alanine aminotransferase \> 40IU/L, or aspartate aminotransferase \> 40IU/L;
Outcomes
Primary Outcomes
Restoration of corneal surface in the diseased eye
Time Frame: 1 year
Restoration of a completely epithelized, stable, and avascular corneal surface in the diseased eye.
Restoration of corneal surface in the fellow eye
Time Frame: 1 year
Restoration of a completely epithelized, stable, and avascular corneal surface in the fellow eye.
Secondary Outcomes
- Uncorrected and best-corrected visual acuity in both eyes(1 year)
- Corneal power, astigmatism and aberration in both eyes(1 year)
- Corneal sensation in both eyes(1 year)
- Corneal thickness in both eyes(1 year)
- Density of stromal nerve and stromal keratocytes in both eyes(1 year)
- Reconstruction of limbal palisades of Vogt in the diseased eye(1 year)
- Corneal haze in both eyes(1 year)
Investigators
Chunxiao Wang
Clinical investigator
Sun Yat-sen University
Study Sites (1)
Loading locations...
Similar Trials
Unknown
Not Applicable
Corneal Epithelial Autograft for PterygiumPterygiumNCT03217500Chunxiao Wang45
Completed
Not Applicable
Corneal Autograft for Limbal DermoidCorneal DermoidNCT03217461Chunxiao Wang19
Completed
Not Applicable
Corneal Epithelial Allograft From Living-related Donor for LSCDLimbal Stem Cell DeficiencyNCT03217435Chunxiao Wang20
Unknown
Not Applicable
Femtosecond Laser-assisted Corneal Debridement for Herpes Simplex KeratitisHerpes Simplex KeratitisNCT03217474Chunxiao Wang100
Completed
Phase 4
Clear Corneal Incisions and Arcuate Incisions Utilizing FemtoSecond Laser Technology for Cataract SurgeryCataractsNCT01383057Innovative Medical29